Relating to permissible accountability interventions for certain school districts with low-performing campuses.
Relating to the use of opioid antagonists on the campuses of public and private schools and institutions of higher education and at or in transit to or from off-campus school events.
Relating to the administration of opioid antagonists by a school nurse at public school campuses.
Relating to the use of glucagon medication on certain public and private school campuses.
Relating to the inclusion of a school safety domain for evaluating districts and campuses under the public school accountability system.
Relating to the establishment of a grant program for school districts or open-enrollment charter school campuses that are designated as full-service community schools.
Relating to the establishment of a grant program for school districts or open-enrollment charter school campuses that are designated as full-service community schools.
Relating to the establishment of a grant program for school districts or open-enrollment charter school campuses that are designated as full-service community schools.
Relating to the implementation of student and family engagement plans by school districts.
Relating to the use of medication designated for treatment of respiratory distress on public and private school campuses.